Immunogenic cell death-related risk signature for tumor microenvironment profiling and prognostic prediction in colorectal cancer
- Pengcheng Wang 1, Wei Zhao 2, Linghong Guo 1, Hailei Cao 3
- Pengcheng Wang 1, Wei Zhao 2, Linghong Guo 1
- 1Colorectal Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
- 2Department of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- 3Department of Colorectal and Anal Surgery, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
- 0Colorectal Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identifies three immunogenic cell death (ICD) genes (CLMP, NRP1, PLEKHO1) that predict colorectal cancer (CRC) survival and chemotherapy response, offering new prognostic tools.
Area Of Science
- Oncology
- Immunology
- Genetics
Background
- Immunogenic cell death (ICD) influences the tumor immune microenvironment and adaptive immunity.
- The clinical role of ICD-associated genes in colorectal cancer (CRC) is not well understood.
Purpose Of The Study
- To identify ICD-related genes and develop a prognostic model for colorectal cancer (CRC).
- To investigate the association between the developed risk score and immune cell infiltration and chemotherapy sensitivity in CRC.
Main Methods
- Weighted gene co-expression network analysis (WGCNA) and LASSO regression were used to identify key ICD genes and construct a risk score (ICDRS).
- ESTIMATE, Gene Set Enrichment Analysis (GSEA), and the oncoPredict package were employed to assess immune infiltration and drug sensitivity.
- In vitro experiments validated gene expression and functional roles.
Main Results
- Three prognostic genes (CLMP, Neuropilin-1 (NRP1), and PLEKHO1) were identified and used to build the ICDRS.
- A high ICDRS independently predicted poorer overall survival (OS) in CRC patients and correlated with increased immune cell infiltration.
- The ICDRS showed significant correlation with sensitivity to chemotherapeutic drugs, and NRP1 promoted CRC cell proliferation, migration, and invasion.
Conclusions
- The ICD-related risk score (ICDRS) serves as a reliable prognostic predictor for colorectal cancer (CRC).
- The ICDRS has potential utility in guiding personalized chemotherapy strategies for CRC patients.
- CLMP, NRP1, and PLEKHO1 are differentially expressed in CRC and NRP1 plays a functional role in CRC progression.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

